Navin Fluorine introduces Navin Molecular Brand

Navin Fluorine International Ltd (NFIL), part of the Padmanabh Mafatlal Group, has unveiled the new identity for its contract development and manufacturing division, Navin Molecular. The future-thinking brand is designed to meet the emerging need for reliable, fast, and cost-effective custom synthesis and manufacturing services for the pharmaceutical and speciality chemicals industries .

The new brand is being launched to showcase the broad platform that Navin Molecular can offer and will focus on two key value propositions. Firstly, to allow customers to build a geographically diverse supply chain that operates to internationally recognized standards for quality, safety and the environment. And secondly, to provide world-class facilities and strong expertise across the full range of complex chemistry that are required to manufacture advanced intermediates , including a range of extremely hazardous and challenging chemistries, as perpharmabiz.

The rebranding is an important step in a customer-focused strategy to consolidate Navin Molecule’s extensive expertise into three core offerings: bespoke synthesis, contract manufacturing, and process and analytical development. The new identity emphasizes the company's vast experience in traditional small-molecule chemical development and contract synthesis, while remaining connected to the parent company's fluorination heritage and competence. Rajendra Kumar Sahu, chief executive of Navin Molecular said: “Since 2010 our CDMO division has been providing chemistry services which encompass a wide range of technologies.

And, whilst direct fluorination and other hazardous chemistries remain core competencies, we’ve been working hard to integrate the full range of our expertise into the portfolio. The creation of the Navin Molecular brand is really the culmination of this work and, now that the rebrand is complete, we are very excited to share the details with our customers as we work towards being the partner of choice for the global pharmaceutical and speciality chemicals industry.”